Table 2.

Results of univariate analysis for all patients.

Characteristic	Median survival (months)	95% CI	P a
Age (years)			.0008
≤50	13	11.06–14.94
>50	7	5.70–8.3
Gender			NS
Male	10	7.52–12.48
Female	8	4.87–11.13
Karnofsky performance status			0004
<70	5.5	3.71–7.29
≥70	12	10.13–13.87
Presence of seizures			.0203
Yes	15	9.12–20.88
No	8	6.37–9.63
Extent of surgery			NS
Complete resection	10	6.55–13.45
Subtotal resection	8	5.28–11.52
Radiotherapy dose			.0008
<60 Gy	4	0.64–7.36
≥60 Gy	11	8.94–13.06
Concomitant TMZ			.0019
Yes	16	9.30–22.70
No	8	6.09–9.91

^aVersus two characteristics in each category

TMZ: Temozolomide; NS: not significant.